2STEIN M E, BEN-SCHACHER M, KUTON A, et al. Primary lymphoma of the liver: clinical features and outcome of 9 patients[J]. J BUON, 2005, 10 (4) : 505- 509.
3NASR BEN AMMAR C, CHAARI N, KOCHBATI L, et al. Primary non-Hodgkin lymphoma of the liver: case re-port and review of the literature [ J ]. Cancer Radiother (法文), 2006, 10 (8): 595-601.
1Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin, 1998, 48 ( 1 ): 6-29.
2Ghetie MA, Bright H, Vitetta ES. Homodimers but not monomers of rituxan (chimeric anti-CD20 ) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin. Blood, 2001,97 (5): 1392-1398.
3Vose JM, Link BK, Grossbard ML, et al. Phase Ⅱ study of rituximab in combination with chop chemotherapy in patients with previously untreated,aggressive non-Hodgkin's lymphoma. J Clin Oncol, 2001, 15, 19 (2):389-397.
4Bienvenu J, Chvetzoff R, Salles G, et al. Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J, 2001,2 (6): 378-384.
5Hans CP, Weisenburger DD, Greiner TC,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a ussue microarray [J]. Blood, 2004, 103(1): 275-282.
6Jaffy ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues [M]. Lyon: IARC Press, 2001. 111-113.
7Rossi D, Gaidano G. Molecular heterogeneity of diffuse large Bcell lymphoma: implications for disease management and prognosis[J]. Hematology, 2002, 7(4): 239-252.
8Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J]. Nature, 2000, 403(6769): 503-511.
9Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B--cell lymphoma[J]. N Engl J Med, 2002, 346(25): 1937-1947.
10Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lym- phoma outcome prediction by gene--expression profiling and su- pervised machine learning[J]. Nat Med, 2002, 8(1): 68-74.
7UPPENKAMP M,FELLER A C.Classification of mal-ignant lymphoma[J].Onkologie,2002,25(6):563-570.
8RUSKONE-FOURMESTRAUX A,DELMER A,HENNEQUIN C.Gastrointestinal lymphomas[J].Gastroenterol Clin Biol,2006,30(Spec No 2):2S81-2S90.
9FISCHBACH W,DRAGOSICS B,KOLVE-GOEBELER M E,et al.Primary gastric B-cell lymphoma:results of a prospective multicenter study.The German-Austrian Gastrointestinal Lymphoma Study Group[J].Gastroenterology,2000,119(5):1191-1202.
10JANSSEN J.The impact of EUS in primary gastric lymphoma[J].Best Pract Res Clin Gastroenterol,2009,23(5):671-678.
